🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Tablet(s) Serving Size
30 Servings
Other Combinations Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

30 mg (270% DV)
✅ 2.7× RDA — within safe limits 📚 258 studies (Tier A: 6, B: 134)
RDA 11mg This product: 30mg UL 40mg
1000 mg
📊 Market median: 500.0mg (159 products)
Median 500.0mg This product: 1000mg

Other Ingredients

Cellulose Magnesium Silicate Polyethylene Glycol Polyvinyl Alcohol Silica Titanium Dioxide Magnesium Stearate Stearic Acid

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (90% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Directions: For adults, take two (2) tablets daily, preferably with a meal.

⚠️ Warnings & Precautions

Warning: If you are pregnant, nursing, taking any medications or have any medical condition, consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur.

Keep out of reach of children.

Do not use if seal under cap is broken or missing.

🧪 Formulation Notes

L-Lysine & Zinc 1,000mg & 30mg per serving

Immune support formula

No artificial flavor or sweetener, no sugar, no starch, no milk, no lactose, no soy, no gluten, no wheat, no yeast, no fish. Sodium free.

Additional Information

Store at room temperature.

To reorder item # 26132 www.puritan.com 1-800-645-1030

QA Quality Assured

Made in the USA with select ingredients from around the world

Product Details

UPC / SKU 0 25077 00135 4
DSLD Entry Date 2023-06-22
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 286165
Data Updated 2026-04-11

Research Evidence

3 Research Sources
74 Avg Quality Score
3 Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013
View all evidence for Lysine →

Compare Similar Products

View all Lysine products →